Healthcare / Medical DevicesUpdated 2026-05-10 22:07 UTC

LIVN stock hub

LivaNova PLC has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

LIVNis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

3.9B

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

LIVN

In the news

Latest news · LIVN

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E16.8

P25 12.6P50 18.3P75 33.7

Trailing P/E37

P25 15P50 23.3P75 38.5

ROE9.5

P25 -106.6P50 -46.9P75 -3.1

ROIC18.8

P25 -63.1P50 -27.5P75 -0

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All LIVN market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

250

Groups with data

Currency

USD

Showing 250 of 250 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001639691
Company name	LivaNova PLC
Country	United Kingdom
Country code	US
Cusip	G5509L101
Employees	3,300
Employees Change	400%
Employees Change Percent	13.79
Enterprise value	$3.8B
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Medical Devices
IPO Date	1993-02-10
Isin	GB00BYMT0J19
Last refreshed	2026-05-10
Market cap	$3.9B
Market cap category	Mid-Cap
Price	$71.86
Price currency	USD
Rev Per Employee	434,380.61x
Sector	Healthcare
Sic	3845
Symbol	LIVN
Website	https://www.livanova.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	2.71%
EV Earnings	35.01x
EV Sales Forward	2.42x
EV/EBIT	17.53x
EV/EBITDA	14.29x
EV/FCF	23.29x
EV/Sales	2.62x
FCF yield	4.08%
Forward P/E	16.83x
P/B ratio	3.26x
P/E ratio	36.99x
P/S ratio	2.75x
PEG ratio	1.09x
PS Forward	2.55x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	14.93%
EBITDA Margin	18.31%
FCF margin	11.23%
Gross margin	67.85%
Gross Profit	$972.7M
Gross Profit Growth	12.62%
Gross Profit Growth Q	13.22%
Gross Profit Growth3 Y	11.46%
Gross Profit Growth5 Y	11.16%
Net Income	$107.1M
Net Income Growth Quarters	1%
Net Income Growth Years	0%
Pretax Margin	8.47%
Profit Margin	7.47%
Profit Per Employee	$32,468
ROA	5.27
Roa5y	2.96
ROCE	12.2
ROE	9.54
Roe5y	-6.23
ROIC	18.75
Roic5y	7.4

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	3.54%
Cagr15y	5.22%
Cagr1y	65.25%
Cagr20y	5.7%
Cagr3y	14.81%
Cagr5y	-2.84%
EPS Growth Quarters	1
EPS Growth Years	0
FCF Growth	10.66%
FCF Growth Q	-92.97%
FCF Growth3 Y	64.97%
FCF Growth5 Y	69.66%
OCF Growth	24.65%
OCF Growth Q	-36.51%
OCF Growth10 Y	11.83%
OCF Growth3 Y	55.87%
OCF Growth5 Y	39.73%
Revenue Growth	12.39x
Revenue Growth Q	14.33x
Revenue Growth Quarters	14x
Revenue Growth Years	3x
Revenue Growth3 Y	11.11x
Revenue Growth5 Y	8.82x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.56
Assets	$2.5B
Cash	$539.7M
Current Assets	$1B
Current Liabilities	$762.5M
Debt	$343.4M
Debt EBITDA	$1.24
Debt Equity	$0.28
Debt FCF	$2.13
Equity	$1.2B
Interest Coverage	5.06
Liabilities	$1.3B
Long Term Assets	$1.5B
Long Term Liabilities	$542.5M
Net Cash	$196.3M
Net Cash By Market Cap	$4.97
Net Cash Growth	223.94%
Net Debt EBITDA	$-0.75
Net Debt Equity	$-0.16
Net Debt FCF	$-1.22
Tangible Book Value	$201.2M
Tangible Book Value Per Share	$3.66
WACC	8.93

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.33
Inventory Turnover	2.88
Net Working Capital	$-276.4M
Quick ratio	1.01
Working Capital	$251.8M
Working Capital Turnover	$4.21

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-1.08%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	41.65%
1Y total return	65.2%
200-day SMA	59.14
3Y total return	51.35%
50-day SMA	63.74
50-day SMA vs 200-day SMA	50over200
5Y total return	-13.41%
All Time High	131.5
All Time High Change	-45.37%
All Time High Date	2018-09-12
All Time Low	1.88
All Time Low Change	3,732.53%
All Time Low Date	1994-10-18
ATR	2.88
Beta	0.82
Beta1y	1.36
Beta2y	0.89
Ch YTD	16.79
High	72.51
High52	72.51
High52 Date	2026-05-08
High52ch	-0.9%
Low	70.32
Low52	41.02
Low52 Date	2025-08-01
Low52ch	75.2%
Ma50ch	12.73%
Price vs 200-day SMA	21.51%
RSI	66.26
RSI Monthly	61.48
RSI Weekly	61.97
Sharpe ratio	1.4x
Sortino ratio	2.75
Total Return	-1.08%
Tr YTD	16.79
Tr15y	114.64%
Tr1m	13.09%
Tr1w	17.8%
Tr3m	7.96%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	7
Analyst Count Top	1
Analyst Price Target Top	$70
Analyst Ratings	Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$0.86
Earnings EPS Estimate Growth	-2.27
Earnings Revenue Estimate	346,824,536x
Earnings Revenue Estimate Growth	9.44x
Operating Income	$214M
Operating Income Growth	16.89
Operating Income Growth Q	5.25
Operating Income Growth3 Y	68.27
Operating margin	14.93
Price target	$76.29
Price Target Change	$6.17
Price Target Change Top	$-2.59

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	54,684,365%
Float Percent	99.55%
Net Borrowing	-372,490,000
Shares Insiders	0.4%
Shares Institutions	104.39%
Shares Out	54,933,538
Shares Qo Q	2.65%
Shares Yo Y	1.08%
Short Float	5.84%
Short Ratio	4.27
Short Shares	5.82

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$124.3M
Average Volume	888,644.5x
Bv Per Share	22.06
CAPEX	$-84.6M
Ch10y	41.65
Ch15y	114.6
Ch1m	13.09
Ch1w	17.8
Ch1y	65.2
Ch20y	203
Ch3m	7.96
Ch3y	51.35
Ch5y	-13.41
Ch6m	42.44
Change	1.31%
Change From Open	0.86
Close	70.93
Days Gap	0.45
Depreciation Amortization	48,493,000
Dollar Volume	64,767,274.3
Earnings Date	2026-05-06
Earnings Time	bmo
EBIT	$214M
EBITDA	$262.5M
EPS	$1.94
F Score	7
FCF	$161M
FCF EV Yield	4.29x
FCF Per Share	$2.93
Financing CF	-375,484,000
Fiscal Year End	December
Founded	1,987
Goodwill	785,590,000
Graham Number	31.055
Graham Upside	-56.78
Income Tax	$14.3M
Investing CF	-76,864,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-06
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-02-25
Ma150	61.45
Ma150ch	16.94%
Ma20	64.11
Ma20ch	12.09%
Net CF	-198,731,000
Next Earnings Date	2026-08-05
Open	71.25
Optionable	Yes
P FCF Ratio	24.51
P OCF Ratio	16.07
Position In Range	70.32
Ppne	310,015,000
Price Date	2026-05-08
Price EBITDA	$15.04
Ptbv Ratio	19.62
Relative Volume	1.01x
Revenue	1,433,456,000x
SBC By Revenue	2.57x
Share Based Comp	36,779,000
Tax By Revenue	1x
Tax Rate	11.79%
Tr20y	202.95%
Tr6m	42.44%
Volume	901,298
Z Score	1.68

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does LIVN pay a dividend?

Capital-return profile for this ticker.

Performance

LIVN stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns LIVN?

Insider, institutional, and short-interest positioning.

Institutional ownership

+104.4%

Float: +99.5% of shares outstanding

Insider ownership

+0.4%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

LIVN momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

66.3

Neutral momentum band

Price vs 200-day MA

+21.5%

50/200-day relationship not available

Beta (5Y)

0.82

Moves roughly with the market

Sharpe ratio

1.40

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About LIVN

Hub-level FAQ points readers to the deeper analysis pages.

What is the current LIVN stock rating?

LivaNova PLC is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full LIVN analysis?

The full report lives at /stocks/LIVN/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for LIVN?

The latest report frames LIVN around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the LIVN page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.